Table 4 Reproductive outcomes between Bakri balloon group vs control group
From: Menstrual and reproductive outcomes after use of balloon tamponade for severe postpartum hemorrhage
Bakri balloon only (n = 39) (SD) | Control (n = 161) (SD) | p-value; MD; 95% CI | |
|---|---|---|---|
Use of contraception | 18 (46.2%) | 100 (62.1%) | 0.07 |
Subsequent pregnancies# | 9 (42.9%) | 28 (45.9%) | 0.81 |
Occurrence after index delivery†(months) | 28.4 (13.0); range 11–48 | 28.6 (10.9); range 10–52 | 0.98; −0.13; −8.99 to 8.74 |
Miscarriage | 2 (9.5%) | 5 (8.2%) | 1.00 |
Termination | 1 (4.8%) | 5 (8.2%) | 1.00 |
Ectopic | 1 (4.8%) | 2 (3.3%) | 1.00 |
Deliveries | 5 (23.8%) | 16 (26.2%) | 0.83 |
Vaginal delivery | 4 | 11 | |
Caesarean section | 1 | 6 | |
Presence of PPH | 2 | 6 |